Enrichment of highly abundant epigenetic marks from endometrial stromal cells

Chromatrap®, the novel solid-based matrix for chromatin immunoprecipitation (ChIP) assays, available from Porvair Sciences, has been successfully used to isolate high quality chromatin from difficult biopsy material.

Focusing on the precipitation of epigenetic marks from primary endometrial stromal cells, researchers have produced excellent enrichment of high abundant epigenetic marks from 1 million cells isolated from a tissue biopsy. The selective enrichment using Chromatrap was highlighted by the selective amplification of both positive and negative gene targets relative to negative IgG. Further the work described demonstrates how the Chromatrap ChIP Assay Kit is able to delineate the balance between active and repressive associated marks and also is compatible with human tissue.

The protocol to enrich epigenetic histone marks from primary human tissue cells is detailed in an application note that may be downloaded from www.chromatrap.com/downloads/.

Chromatrap® uses a solid phase porous polymer functionalised with protein A or G, allowing much greater chromatin and antibody capturet than bead based methods. The Chromatrap spin column approach offers significant advantages compared to traditional methods based on sepharose or magnetic beads, which involve many steps of separation, pipetting and re-suspension. Independent tests with Chromatrap demonstrate the reproducibility of the assay and the strong fold amplification above negative IgG background, enables the targeting of both abundant and low abundant marks at multiple gene targets. Levels of DNA pull down are up to 25 times higher than with traditional bead based procedures and top performance even with samples as small as 50ng-3000ng chromatin per immunoprecipitation enables Chromatrap to be used on small scale biopsies.

For further information about the Chromatrap® ChIP assay technology and related ChIP products please visit www.chromatrap.com or contact Porvair Sciences on +44-1978-666239 or [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chromatrap® - Porvair Sciences Ltd. (2014, May 01). Enrichment of highly abundant epigenetic marks from endometrial stromal cells. News-Medical. Retrieved on August 21, 2019 from https://www.news-medical.net/news/20140430/Enrichment-of-highly-abundant-epigenetic-marks-from-endometrial-stromal-cells.aspx.

  • MLA

    Chromatrap® - Porvair Sciences Ltd. "Enrichment of highly abundant epigenetic marks from endometrial stromal cells". News-Medical. 21 August 2019. <https://www.news-medical.net/news/20140430/Enrichment-of-highly-abundant-epigenetic-marks-from-endometrial-stromal-cells.aspx>.

  • Chicago

    Chromatrap® - Porvair Sciences Ltd. "Enrichment of highly abundant epigenetic marks from endometrial stromal cells". News-Medical. https://www.news-medical.net/news/20140430/Enrichment-of-highly-abundant-epigenetic-marks-from-endometrial-stromal-cells.aspx. (accessed August 21, 2019).

  • Harvard

    Chromatrap® - Porvair Sciences Ltd. 2014. Enrichment of highly abundant epigenetic marks from endometrial stromal cells. News-Medical, viewed 21 August 2019, https://www.news-medical.net/news/20140430/Enrichment-of-highly-abundant-epigenetic-marks-from-endometrial-stromal-cells.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Porvair Sciences launches new ChIP-Seq library preparation kit